Recent Soleno-sponsored Posters and Presentations – Content provided on this page is intended for scientific exchange and may include references to, or data/information regarding a Soleno investigational product or use of a Soleno product that has not been FDA approved; no conclusions regarding the safety or efficacy can be made. Furthermore, this information should not be construed as recommendation for use of, or intent to promote a Soleno product for unapproved uses.
The content provided is intended for your personal and educational use only. Any further reproduction or distribution is not permitted without permission from the copyright owners or authors.
Poster
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR 2025)
13-16 May 2025. Montreal, QC, Canada.
Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Cowen N, Gandhi R, Yin S, et al.
